C-peptide secretion in calcific tropical pancreatic diabetes.
Serum C-peptide levels were measured during a glucagon stimulation test in ten normal nonobese controls and 54 diabetic patients with recent onset of diabetes under 30 years of age. Diabetic patients were comprised of 13 CTPD, 23 IDDM, and 18 NIDDM. As similar to IDDM patients, serum C-peptide concentrations did not rise significantly (P greater than 0.05) in response to glucagon administration in CTPD-patients. Mean baseline and peak serum C-peptide concentrations in CTPD-patients were significantly lower (P less than 0.001) than the values in normal controls and NIDDM patients, but were significantly higher (P less than 0.05) than those in IDDM patients. We conclude that CTPD patients have partial C-peptide reserve, which may protect against ketosis and contribute to ketosis resistance in CTPD. Our results also suggest that CTPD patients require insulin treatment. Neither baseline nor peak C-peptide levels after glucagon could discriminate CTPD from IDDM and CTPD from NIDDM.
D000328:Adult; D002096:C-Peptide / Q000378:metabolism*; D002114:Calcinosis / Q000150:complications; D003920:Diabetes Mellitus / Q000503:physiopathology*; D005260:Female; D005934:Glucagon; D006801:Humans; D007515:Islets of Langerhans / Q000502:physiology; D008297:Male; D010182:Pancreatic Diseases / Q000150:complications; D014329:Tropical Climate
D002096:C-Peptide; D005934:Glucagon